IFNG and Miyoshi myopathy: Nonetheless, no positive effect of lenalidomide on NK cell activation, degranulation or secretion of IFN-γ or MIP1-β was observed in the study that was monitoring NK cell activity and functionality in 10 MM patients treated with lenalidomide-containing regimen and then maintained with lenalidomide.